Patents by Inventor Michael D. Thompson

Michael D. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20200115344
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: December 16, 2019
    Publication date: April 16, 2020
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20190276408
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: October 11, 2018
    Publication date: September 12, 2019
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 10272078
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: April 30, 2019
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20190022080
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: February 5, 2018
    Publication date: January 24, 2019
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 10118897
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: November 6, 2018
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 9918977
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: March 20, 2018
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Process for making isoquinoline compounds
    Patent number: 9708269
    Abstract: The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: July 18, 2017
    Assignee: FibroGen, Inc.
    Inventors: Michael D. Thompson, Jung Min Park, Michael P. Arend
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20170190667
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: March 17, 2017
    Publication date: July 6, 2017
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
    Patent number: 9643928
    Abstract: The present disclosure relates to crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid (Compound A), the process of preparing crystalline forms of Compound A, the pharmaceutical compositions containing them, and the methods of use thereof.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: May 9, 2017
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Michael D. Thompson, Jung Min Park, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 9617218
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: April 11, 2017
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20160331741
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: May 18, 2016
    Publication date: November 17, 2016
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • PROCESS FOR MAKING ISOQUINOLINE COMPOUNDS
    Publication number: 20160194285
    Abstract: The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
    Type: Application
    Filed: March 17, 2016
    Publication date: July 7, 2016
    Inventors: Michael D. Thompson, Jung Min Park, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 9371288
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: June 21, 2016
    Assignee: FibroGen, Inc.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Process for making isoquinoline compounds
    Patent number: 9340511
    Abstract: The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: May 17, 2016
    Assignee: FibroGen, Inc.
    Inventors: Michael D. Thompson, Jung Min Park, Michael P. Arend
  • CRYSTALLINE FORMS OF -ACETIC ACID
    Publication number: 20160002170
    Abstract: The present disclosure relates to crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid (Compound A), the process of preparing crystalline forms of Compound A, the pharmaceutical compositions containing them, and the methods of use thereof.
    Type: Application
    Filed: January 23, 2014
    Publication date: January 7, 2016
    Inventors: Claudia WITSCHI, Michael D. THOMPSON, Jung Min PARK, Michael P. AREND
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20150322015
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: July 21, 2015
    Publication date: November 12, 2015
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Crystalline forms of a prolyl hydroxylase inhibitor
    Patent number: 9115085
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: August 25, 2015
    Assignee: FIBROGEN, INC.
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
  • Method and apparatus for determining a degree of cure in an ultraviolet printing system
    Patent number: 9067436
    Abstract: An approach is provided for determining a degree of curing of one or more ultraviolet sensitive inks. The approach involves causing, causing, at least in part, one or more ultraviolet inks to be applied to a substrate to form an image. The approach also involves causing, at least in part, the image to be exposed to ultraviolet light produced by one or more ultraviolet light sources to cause, at least in part, the one or more ultraviolet inks to be cured to form a cured image. The approach additionally involves determining a reflectance value of the cured image. The approach further involves determining a degree of cure of the cured image based, at least in part, on the reflectance value. The approach may be used to alter the degree of curing of another image applied to a substrate.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: June 30, 2015
    Assignee: Xerox Corporation
    Inventors: Palghat Srinivas Ramesh, Michael D. Thompson, David A. Vankouwenberg
  • PROCESS FOR MAKING ISOQUINOLINE COMPOUNDS
    Publication number: 20150175550
    Abstract: The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
    Type: Application
    Filed: July 15, 2013
    Publication date: June 25, 2015
    Inventors: Michael D. Thompson, Jung Min Park, Michael P. Arend
  • CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
    Publication number: 20150038529
    Abstract: The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: October 21, 2014
    Publication date: February 5, 2015
    Inventors: Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend